23
Apr

Kala Pharmaceuticals, co-founded by MIT biotech luminary Robert Langer, has closed a $22.5 million B round, cash the company says will help advance its novel approach to eye treatments.

…read more

Source: Kala reels in $22.5M to get its next-gen eye drops into PhIII

    

0 No comments